IceCure Medical (NASDAQ:ICCM) & SANUWAVE Health (OTCMKTS:SNWV) Head-To-Head Analysis

IceCure Medical (NASDAQ:ICCM) and SANUWAVE Health (OTCMKTS:SNWV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Profitability

This table compares IceCure Medical and SANUWAVE Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-376.85%	-124.44%	-87.70%
SANUWAVE Health	-1.33%	-23.83%	-20.70%

Institutional & Insider Ownership

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 42.5% of SANUWAVE Health shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 36.6% of SANUWAVE Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares IceCure Medical and SANUWAVE Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.67 million	16.16	-$14.65 million	($0.29)	-4.48
SANUWAVE Health	$20.40 million	9.22	-$25.81 million	$8.32	2.65

IceCure Medical has higher earnings, but lower revenue than SANUWAVE Health. IceCure Medical is trading at a lower price-to-earnings ratio than SANUWAVE Health, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for IceCure Medical and SANUWAVE Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0	0	1	1	3.50
SANUWAVE Health	0	0	0	0	0.00

IceCure Medical currently has a consensus target price of $2.70, suggesting a potential upside of 107.69%. Given IceCure Medical’s stronger consensus rating and higher possible upside, equities research analysts plainly believe IceCure Medical is more favorable than SANUWAVE Health.

Risk & Volatility

IceCure Medical has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, SANUWAVE Health has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.

Summary

SANUWAVE Health beats IceCure Medical on 9 of the 15 factors compared between the two stocks.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.